Celldex Therapeutics, Inc. - Common Stock, par value $0.001 per share (CLDX)

CUSIP: 15117B202

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
67,629,115
Total 13F shares
27,786,246
Share change
+23,817,439
Total reported value
$361,216,517
Put/Call ratio
27%
Price per share
$13.00
Number of holders
63
Value change
+$310,785,532
Number of buys
47
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 15117B202?
CUSIP 15117B202 identifies CLDX - Celldex Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Celldex Therapeutics, Inc. - Common Stock, par value $0.001 per share (CLDX) as of Q2 2020

As of 30 Jun 2020, Celldex Therapeutics, Inc. - Common Stock, par value $0.001 per share (CLDX) was held by 63 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,786,246 shares. The largest 10 holders included BVF INC/IL, RTW INVESTMENTS, LP, Logos Global Management LP, Redmile Group, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Ikarian Capital, LLC, RENAISSANCE TECHNOLOGIES LLC, Vivo Capital, LLC, VANGUARD GROUP INC, and RA CAPITAL MANAGEMENT, L.P.. This page lists 63 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.